These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27627451)

  • 1. [Epigastric pain and vomiting in a patient with ankylosing spondylitis].
    Serrano-Martínez JL; Redondo-Orts M; Zambudio-Carroll N; Pasquau-Liaño J
    Rev Esp Quimioter; 2016 Oct; 29(5):280-2. PubMed ID: 27627451
    [No Abstract]   [Full Text] [Related]  

  • 2. Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab.
    Cooper J; Flückiger B; Traichl B; Diener PA; Otto P; von Kempis J
    J Clin Rheumatol; 2009 Aug; 15(5):244-6. PubMed ID: 19590442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feeding intolerance secondary to marked hepatosplenomegaly compressing the stomach in children.
    Donnelly LF; Paterson A
    Pediatr Radiol; 2000 Sep; 30(9):653. PubMed ID: 11009307
    [No Abstract]   [Full Text] [Related]  

  • 4. Nausea, vomiting, and epigastric pain in an elderly diabetic.
    Medero M; Hoffman D; Lineaweaver W; King C; Rumley TO
    JAMA; 1985 Sep; 254(11):1485-6. PubMed ID: 4032652
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastroduodenal involvement, with pain, vomiting, and weight loss.
    Ansari A; Anderson Q; Hoppes E; Henrikson E
    JAMA; 1976 May; 235(18):2013-4. PubMed ID: 946521
    [No Abstract]   [Full Text] [Related]  

  • 6. Infliximab therapy for inflammatory discitis in ankylosing spondylitis.
    Joshi N; Nautiyal A; Walton T
    J Clin Rheumatol; 2012 Mar; 18(2):109-10. PubMed ID: 22367694
    [No Abstract]   [Full Text] [Related]  

  • 7. Fractures of the dens complicating ankylosing spondylitis with atlantooccipital fusion.
    Miller FH; Rogers LF
    J Rheumatol; 1991 May; 18(5):771-4. PubMed ID: 1865430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy.
    Yoo JW; Jo KW; Kang BH; Kim MY; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Eur Respir J; 2014 Nov; 44(5):1289-95. PubMed ID: 25102962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Golimumab may induce exacerbation of inflammatory bowel disease when it is used for the treatment of ankylosing spondylitis: a case report with a review of literature.
    Bawany MZ; Rafiq E; Thotakura R; Lay R; Silverman AL; Nawras A
    Am J Ther; 2014; 21(1):e26-7. PubMed ID: 23344099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ankylosing spondylitis and Crohn's disease successfully treated with infliximab.
    Rebelo A; Leite S; Cotter J
    BioDrugs; 2010 Dec; 24 Suppl 1():37-9. PubMed ID: 21175236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis.
    Tong Q; Cai Q; de Mooij T; Xu X; Dai S; Qu W; Zhao D
    PLoS One; 2015; 10(3):e0119897. PubMed ID: 25764452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease, ankylosing spondylitis, and IgA nephropathy.
    de Moura CG; de Moura TG; de Souza SP; Testagrossa L
    J Clin Rheumatol; 2006 Apr; 12(2):106-7. PubMed ID: 16601553
    [No Abstract]   [Full Text] [Related]  

  • 13. Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab.
    Azevedo VF; Paiva E; Tosin T; Ferreira A; Ferreira AM; Fernandes M
    Reumatismo; 2011 Nov; 63(3):171-4. PubMed ID: 22257918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs.
    Perrotta FM; Addimanda O; Ramonda R; D'Angelo S; Lubrano E; Marchesoni A; Olivieri I; Punzi L; Salvarani C; Spadaro A
    Reumatismo; 2014 Nov; 66(3):208-14. PubMed ID: 25376955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoracic Manifestations of Ankylosing Spondylitis, Inflammatory Bowel Disease, and Relapsing Polychondritis.
    Danve A
    Clin Chest Med; 2019 Sep; 40(3):599-608. PubMed ID: 31376894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor necrosis factor alpha and ankylosing spondylitis.
    Asli B; Wechsler B; Lemaître C
    N Engl J Med; 2003 Jan; 348(4):359-61; author reply 359-61. PubMed ID: 12540654
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab.
    Simón JA; Burgos-Vargas R
    Dermatology; 2008; 216(3):234-5. PubMed ID: 18182816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary involvement in ankylosing spondylitis.
    Quismorio FP
    Curr Opin Pulm Med; 2006 Sep; 12(5):342-5. PubMed ID: 16926649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of comorbidities in ankylosing spondylitis.
    Rosenbaum J; Chandran V
    Am J Med Sci; 2012 May; 343(5):364-6. PubMed ID: 22543539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of anti-tumor necrosis factor therapy for extra-articular manifestations in patients with ankylosing spondylitis: a meta-analysis.
    Wu D; Guo YY; Xu NN; Zhao S; Hou LX; Jiao T; Zhang N
    BMC Musculoskelet Disord; 2015 Feb; 16(1):19. PubMed ID: 25888248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.